This study identified a set of four biomarkers, Angiopoietin 1/2, IFN‐γ, IL‐6, and plasminogen activator inhibitor 1, which could categorize two phenotypic groups of ARDS patients. This evidence concerns the gene IL6 and acute respiratory distress syndrome.